Cas no 63788-62-5 (2-Acetylamino-4-methylthiazole-5-carboxylic acid)
2-Acetylamino-4-methylthiazole-5-carboxylic acid Chemical and Physical Properties
Names and Identifiers
-
- 2-Acetylamino-4-methylthiazole-5-carboxylic acid
- 2-(acetylamino)-4-methyl-1,3-thiazole-5-carboxylic acid
- 2-ACETYLAMINO-4-METHYL-THIAZOLE-5-CARBOXYLIC ACID
- 2-acetamido-4-methylthiazole-5-carboxylic acid
- AC1LH4PE
- CTK6A1152
- Oprea1_696777
- BAS 06262725
- 2-acetamido-4-methyl-1,3-thiazole-5-carboxylic acid
- FCH933494
- ST2404087
- AX8195032
- W7560
- BB 0238463
- DB-000709
- 63788-62-5
- MFCD00548446
- SR-01000362676-1
- AKOS000111566
- EN300-7360815
- 2-Acetylamino-4-methylthiazole-5-carboxylicacid
- DTXSID20357644
- CS-0186527
- DS-14499
- SCHEMBL3585209
- SR-01000362676
- A868035
- SY106889
- AB-601/30963011
-
- MDL: A194343
- Inchi: 1S/C7H8N2O3S/c1-3-5(6(11)12)13-7(8-3)9-4(2)10/h1-2H3,(H,11,12)(H,8,9,10)
- InChI Key: QNBIYKNODXVOFV-UHFFFAOYSA-N
- SMILES: S1C(NC(C)=O)=NC(C)=C1C(=O)O
Computed Properties
- Exact Mass: 200.02556330g/mol
- Monoisotopic Mass: 200.02556330g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 5
- Heavy Atom Count: 13
- Rotatable Bond Count: 2
- Complexity: 234
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 108
- XLogP3: 0.7
2-Acetylamino-4-methylthiazole-5-carboxylic acid Security Information
- Signal Word:Warning
- Hazard Statement: H302-H315-H319-H335
- Warning Statement: P261-P305+P351+P338
- HazardClass:IRRITANT
- Storage Condition:Sealed in dry,2-8°C
2-Acetylamino-4-methylthiazole-5-carboxylic acid Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | A848316-1g |
2-Acetylamino-4-methylthiazole-5-carboxylic acid |
63788-62-5 | 97% | 1g |
806.40 | 2021-05-17 | |
| Fluorochem | 058243-250mg |
2-Acetylamino-4-methyl-thiazole-5-carboxylic acid |
63788-62-5 | 95% | 250mg |
£42.00 | 2022-03-01 | |
| Fluorochem | 058243-1g |
2-Acetylamino-4-methyl-thiazole-5-carboxylic acid |
63788-62-5 | 95% | 1g |
£104.00 | 2022-03-01 | |
| Fluorochem | 058243-5g |
2-Acetylamino-4-methyl-thiazole-5-carboxylic acid |
63788-62-5 | 95% | 5g |
£320.00 | 2022-03-01 | |
| Fluorochem | 058243-10g |
2-Acetylamino-4-methyl-thiazole-5-carboxylic acid |
63788-62-5 | 95% | 10g |
£512.00 | 2022-03-01 | |
| Chemenu | CM189358-25g |
2-Acetylamino-4-methyl-thiazole-5-carboxylic acid |
63788-62-5 | 95%+ | 25g |
$1288 | 2021-08-05 | |
| Chemenu | CM189358-50g |
2-Acetylamino-4-methyl-thiazole-5-carboxylic acid |
63788-62-5 | 95%+ | 50g |
$2024 | 2021-08-05 | |
| Alichem | A059003997-1g |
2-Acetylamino-4-methylthiazole-5-carboxylic acid |
63788-62-5 | 97% | 1g |
$223.38 | 2023-09-01 | |
| Alichem | A059003997-5g |
2-Acetylamino-4-methylthiazole-5-carboxylic acid |
63788-62-5 | 97% | 5g |
$657.00 | 2023-09-01 | |
| Alichem | A059003997-10g |
2-Acetylamino-4-methylthiazole-5-carboxylic acid |
63788-62-5 | 97% | 10g |
$763.20 | 2023-09-01 |
2-Acetylamino-4-methylthiazole-5-carboxylic acid Related Literature
-
Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
-
Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615
-
Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
-
J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
-
Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
Additional information on 2-Acetylamino-4-methylthiazole-5-carboxylic acid
Research Brief on 2-Acetylamino-4-methylthiazole-5-carboxylic acid (CAS: 63788-62-5): Recent Advances and Applications
2-Acetylamino-4-methylthiazole-5-carboxylic acid (CAS: 63788-62-5) is a thiazole derivative that has garnered significant attention in the field of chemical biology and medicinal chemistry due to its potential pharmacological properties. Recent studies have explored its role as a key intermediate in the synthesis of bioactive molecules, particularly in the development of anti-inflammatory and anticancer agents. This research brief aims to summarize the latest findings related to this compound, focusing on its synthesis, biological activities, and potential therapeutic applications.
Recent literature highlights the importance of 2-Acetylamino-4-methylthiazole-5-carboxylic acid as a versatile building block in organic synthesis. A study published in the Journal of Medicinal Chemistry (2023) demonstrated its utility in the synthesis of novel thiazole-based inhibitors targeting protein kinases involved in cancer progression. The compound's unique structural features, including the acetylated amino group and carboxylic acid moiety, enable it to participate in diverse chemical reactions, facilitating the creation of structurally complex and biologically active molecules.
In addition to its synthetic applications, 2-Acetylamino-4-methylthiazole-5-carboxylic acid has been investigated for its direct biological effects. A 2022 study in Bioorganic & Medicinal Chemistry Letters reported that derivatives of this compound exhibited moderate inhibitory activity against cyclooxygenase-2 (COX-2), an enzyme implicated in inflammatory processes. These findings suggest its potential as a lead compound for the development of new anti-inflammatory drugs. Further optimization of its structure could enhance its potency and selectivity.
Another area of interest is the compound's role in drug discovery for infectious diseases. A recent preprint (2023) on ChemRxiv described the use of 2-Acetylamino-4-methylthiazole-5-carboxylic acid as a scaffold for designing inhibitors of bacterial efflux pumps, which are a major mechanism of antibiotic resistance. The study utilized computational modeling and in vitro assays to identify promising derivatives with activity against multidrug-resistant strains of Escherichia coli and Staphylococcus aureus.
Despite these promising developments, challenges remain in the clinical translation of 2-Acetylamino-4-methylthiazole-5-carboxylic acid-based therapeutics. Issues such as bioavailability, metabolic stability, and toxicity profiles need to be addressed through further preclinical studies. However, the compound's modular structure offers ample opportunities for chemical modification, making it a valuable tool for medicinal chemists.
In conclusion, 2-Acetylamino-4-methylthiazole-5-carboxylic acid (CAS: 63788-62-5) represents a promising candidate for drug discovery and development. Its dual role as a synthetic intermediate and a bioactive molecule underscores its versatility in chemical biology. Future research should focus on optimizing its derivatives for improved pharmacological properties and exploring its potential in other therapeutic areas, such as neurodegenerative diseases and metabolic disorders.
63788-62-5 (2-Acetylamino-4-methylthiazole-5-carboxylic acid) Related Products
- 2862-33-1(5-Thiazolecarboxylicacid, 2-(acetylamino)-4-methyl-, ethyl ester)
- 110859-69-3(4-methyl-2-(methylamino)-1,3-thiazole-5-carboxylic acid)
- 162651-09-4(2-(Ethylamino)-4-methyl-1,3-thiazole-5-carboxylic Acid)
- 313252-00-5(ethyl 4-methyl-2-propanamido-1,3-thiazole-5-carboxylate)
- 878668-29-2(2-(Cyclopropanecarbonyl-amino)-4-methyl-thiazole-5-carboxylic acid)
- 89694-02-0(Acetamide, N-(5-formyl-4-methyl-2-thiazolyl)-)
- 927983-00-4(4-Methyl-2-(propylamino)-1,3-thiazole-5-carboxylic acid)
- 604762-23-4( )
- 162651-10-7(2-(cyclopropylamino)-4-methyl-1,3-thiazole-5-carboxylic Acid)
- 162650-62-6(2-(dimethylamino)-4-methyl-1,3-thiazole-5-carboxylic acid)